SOD2 and Hyperglycemia: Reduction in mitochondrial ROS formation obtained either through cardiac-specific Mn-SOD overexpression or following stimulation of AMPK activity, prevented mitochondrial damage and many fatty acid- or hyperglycemia-induced events, both in vitro and in vivo (113–116).